Here's Why We Think Neuren Pharmaceuticals (ASX:NEU) Is Well Worth Watching
Jan 15
Have your own idea? Try our Stock Screener
Australian (ASX) Healthcare Sector Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies138
- 7D-0.2%
- 3M0.8%
- 1Y7.3%
- YTD-0.2%
Over the last 7 days, the Healthcare industry has dropped 2.4%, driven by CSL declining 1.9%. On the other hand Telix Pharmaceuticals is actually up 8.7%. This takes the industry's 12 month performance to a gain of 7.3%. Looking forward, earnings are forecast to grow by 18% annually.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jan 2025 | AU$245.4b | AU$69.0b | AU$3.4b | 26.2x | 72.4x | 3.6x |
| Thu, 19 Dec 2024 | AU$246.8b | AU$68.5b | AU$3.3b | 26.2x | 74.1x | 3.6x |
| Sat, 16 Nov 2024 | AU$236.7b | AU$68.1b | AU$3.2b | 24.3x | 73.5x | 3.5x |
| Mon, 14 Oct 2024 | AU$245.1b | AU$67.0b | AU$3.1b | 26.3x | 80.1x | 3.7x |
| Wed, 11 Sep 2024 | AU$239.6b | AU$67.2b | AU$3.1b | 26.4x | 76.7x | 3.6x |
| Fri, 09 Aug 2024 | AU$238.2b | AU$63.1b | AU$2.7b | 28.7x | 89.1x | 3.8x |
| Sun, 07 Jul 2024 | AU$237.2b | AU$62.4b | AU$2.6b | 33.1x | 92.3x | 3.8x |
| Tue, 04 Jun 2024 | AU$225.2b | AU$61.0b | AU$2.6b | 28.3x | 85.2x | 3.7x |
| Thu, 02 May 2024 | AU$220.0b | AU$61.6b | AU$2.7b | 27.3x | 81.9x | 3.6x |
| Sat, 30 Mar 2024 | AU$228.9b | AU$61.6b | AU$2.7b | 27.2x | 85.9x | 3.7x |
| Mon, 26 Feb 2024 | AU$224.2b | AU$61.0b | AU$3.2b | 27.2x | 69.6x | 3.7x |
| Wed, 24 Jan 2024 | AU$229.0b | AU$60.5b | AU$2.9b | 25x | 80.3x | 3.8x |
| Fri, 22 Dec 2023 | AU$222.0b | AU$59.9b | AU$2.8b | 24.9x | 79.7x | 3.7x |
| Sun, 19 Nov 2023 | AU$203.5b | AU$60.7b | AU$2.9b | 24.5x | 70x | 3.4x |
| Tue, 17 Oct 2023 | AU$194.7b | AU$61.5b | AU$3.0b | 24.9x | 65.4x | 3.2x |
| Thu, 14 Sep 2023 | AU$209.2b | AU$61.2b | AU$2.9b | 26.4x | 72.3x | 3.4x |
| Sat, 12 Aug 2023 | AU$210.4b | AU$58.2b | AU$3.0b | 25.9x | 71.2x | 3.6x |
| Mon, 10 Jul 2023 | AU$209.6b | AU$57.7b | AU$2.9b | 28.3x | 72.7x | 3.6x |
| Wed, 07 Jun 2023 | AU$231.3b | AU$57.8b | AU$2.9b | 25.9x | 79.8x | 4x |
| Fri, 05 May 2023 | AU$229.4b | AU$57.2b | AU$2.9b | 28x | 79.9x | 4x |
| Sun, 02 Apr 2023 | AU$222.7b | AU$57.2b | AU$2.9b | 27.6x | 77.8x | 3.9x |
| Tue, 28 Feb 2023 | AU$225.2b | AU$57.2b | AU$3.1b | 23.4x | 71.7x | 3.9x |
| Thu, 26 Jan 2023 | AU$225.8b | AU$54.9b | AU$3.9b | 24.9x | 57.9x | 4.1x |
| Sat, 24 Dec 2022 | AU$217.4b | AU$55.9b | AU$4.1b | 25x | 53.2x | 3.9x |
| Mon, 21 Nov 2022 | AU$222.4b | AU$55.7b | AU$4.1b | 25.9x | 54.5x | 4x |
| Wed, 19 Oct 2022 | AU$210.0b | AU$56.9b | AU$4.3b | 27.3x | 49.2x | 3.7x |
| Fri, 16 Sep 2022 | AU$217.8b | AU$55.4b | AU$4.1b | 28.2x | 53.3x | 3.9x |
| Sun, 14 Aug 2022 | AU$225.2b | AU$53.7b | AU$4.8b | 27.6x | 46.8x | 4.2x |
| Tue, 12 Jul 2022 | AU$216.7b | AU$54.1b | AU$4.9b | 23.5x | 44.6x | 4x |
| Thu, 09 Jun 2022 | AU$208.3b | AU$53.3b | AU$4.7b | 24.7x | 44.2x | 3.9x |
| Sat, 07 May 2022 | AU$212.5b | AU$53.5b | AU$4.8b | 26.1x | 44.4x | 4x |
| Mon, 04 Apr 2022 | AU$212.1b | AU$56.6b | AU$4.6b | 28.9x | 46.4x | 3.8x |
| Wed, 02 Mar 2022 | AU$211.5b | AU$57.3b | AU$4.6b | 26.5x | 45.5x | 3.7x |
| Fri, 28 Jan 2022 | AU$203.5b | AU$55.6b | AU$4.7b | 26.3x | 43.4x | 3.7x |
Price to Earnings Ratio
43.4x
Current Industry PE
- Investors are optimistic on the Australian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 71.9x which is higher than its 3-year average PE of 67.6x.
- The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 10% per year over the last three years.
- Meanwhile revenues for these companies have grown 7.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | 1.86% | |
| Healthcare | -0.22% | |
| Medical Equipment | 2.95% | |
| Healthtech | 1.87% | |
| Pharma | 1.48% | |
| Healthcare Services | 0.16% | |
| Biotech | -1.34% | |
| Life Sciences | -4.03% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 123x.
- Analysts are expecting annual earnings growth of 24.4%, which is higher than its past year's earnings decline of 25.4% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 68% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Biotech industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | AU$26.10 | 8.7% +AU$696.2m | 135.1% | PE177.6x | |
| PME Pro Medicus | AU$258.29 | 1.7% +AU$447.3m | 157.6% | PE326x | |
| COH Cochlear | AU$308.93 | 2.2% +AU$437.7m | 3.3% | PE56.7x | |
| MSB Mesoblast | AU$2.78 | -1.1% AU$256.8m | 892.9% | PS369.3x | |
| NEU Neuren Pharmaceuticals | AU$12.90 | 8.9% +AU$133.4m | -44.5% | PE14x |
